Friedman, H. S., Peters, K. B., Vlahovic, G., Randazzo, D., Boulton, S., Woodring, S., … Desjardins, A. (2015). Phase 1 clinical trial of carboxyamidotriazole orotate (CTO) in combination with lomustine (CCNU) for adult patients with recurrent malignant glioma (MG). In Journal of Clinical Oncology (Vol. 33, pp. e13004–e13004). American Society of Clinical Oncology (ASCO). https://doi.org/10.1200/jco.2015.33.15_suppl.e13004

Friedman, Henry S., Katherine B. Peters, Gordana Vlahovic, Dina Randazzo, Susan Boulton, Sarah Woodring, Eric S. Lipp, et al. “Phase 1 clinical trial of carboxyamidotriazole orotate (CTO) in combination with lomustine (CCNU) for adult patients with recurrent malignant glioma (MG).” In Journal of Clinical Oncology, 33:e13004–e13004. American Society of Clinical Oncology (ASCO), 2015. https://doi.org/10.1200/jco.2015.33.15_suppl.e13004.

Friedman HS, Peters KB, Vlahovic G, Randazzo D, Boulton S, Woodring S, et al. Phase 1 clinical trial of carboxyamidotriazole orotate (CTO) in combination with lomustine (CCNU) for adult patients with recurrent malignant glioma (MG). In: Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. e13004–e13004.

Friedman, Henry S., et al. “Phase 1 clinical trial of carboxyamidotriazole orotate (CTO) in combination with lomustine (CCNU) for adult patients with recurrent malignant glioma (MG).” Journal of Clinical Oncology, vol. 33, no. 15_suppl, American Society of Clinical Oncology (ASCO), 2015, pp. e13004–e13004. Crossref, doi:10.1200/jco.2015.33.15_suppl.e13004.

Friedman HS, Peters KB, Vlahovic G, Randazzo D, Boulton S, Woodring S, Lipp ES, Herndon JE, Healy P, Miller E, Karmali RA, Desjardins A. Phase 1 clinical trial of carboxyamidotriazole orotate (CTO) in combination with lomustine (CCNU) for adult patients with recurrent malignant glioma (MG). Journal of Clinical Oncology. American Society of Clinical Oncology (ASCO); 2015. p. e13004–e13004.